Compounds > nsc305787
Page last updated: 2024-12-08

nsc305787

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID470998
CHEMBL ID2008920
SCHEMBL ID15701262
MeSH IDM0572143

Synonyms (14)

Synonym
nsc305787 ,
[2-(1-adamantyl)-6,8-dichloroquinolin-4-yl]-piperidin-2-ylmethanol
[2-(1-adamantyl)-6,8-dichloroquinolin-4-yl](piperidin-2-yl)methanol
[2-(1-adamantyl)-6,8-dichloro-4-quinolyl]-(2-piperidyl)methanol
HY-18931
CS-5148
SCHEMBL15701262
CHEMBL2008920
785718-37-8
AKOS030526901
nsc 305787
F85307
(rac)-nsc305787
MS-28023

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.88 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
carbostyril
Quinolones: A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.. quinolin-2(1H)-one : A quinolone that is 1,2-dihydroquinoline substituted by an oxo group at position 2.		4.1440monohydroxyquinoline;
quinolone		bacterial xenobiotic metabolite
adamantane
Adamantane: A tricyclo bridged hydrocarbon.		4.8590adamantanes;
polycyclic alkane
nsc668394
[no description available]		4.1440
ConditionIndicatedRelationship StrengthStudiesTrials
Adenocarcinoma, Basal Cell
[description not available]		02.4110
Cancer of Pancreas
[description not available]		03.4550
Adenocarcinoma
A malignant epithelial tumor with a glandular organization.		02.4110
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).		03.4550
B-Cell Chronic Lymphocytic Leukemia
[description not available]		02.4110
Leukemia, Lymphocytic, Chronic, B-Cell
A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.		02.4110
Granulocytic Leukemia
[description not available]		02.3110
Acute Disease
Disease having a short and relatively severe course.		02.3110
Leukemia, Myeloid
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.		02.3110
Carcinoma, Ductal, Pancreatic
[description not available]		02.2110
Carcinoma, Pancreatic Ductal
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.		02.2110
Bone Cancer
[description not available]		03.9340
Cancer of Lung
[description not available]		03.9340
Osteogenic Sarcoma
[description not available]		04.1250
Bone Neoplasms
Tumors or cancer located in bone tissue or specific BONES.		03.9340
Lung Neoplasms
Tumors or cancer of the LUNG.		03.9340
Osteosarcoma
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)		04.1250
Invasiveness, Neoplasm
[description not available]		02.0710